{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:49:37Z","timestamp":1790038177268,"version":"4.0.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nurs"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The ageing population is an international phenomenon. This study investigates the epidemiology of geriatric home care patients in Madinah, Saudi Arabia, focusing on frailty and polypharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional descriptive design was utilised to assess the profiles of home care geriatric patients based on their comprehensive geriatric assessment (CGA) forms from the medical records of the Home Care Administration. Sampling used a census approach involving all eligible CGA forms during the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The sample included 281 patients, predominantly female, with a mean age of 79 years. The logistic regression models for frailty and polypharmacy demonstrated acceptable predictive accuracy and good model fit. Significant predictors of a higher likelihood of frailty were increased age, depression, and diabetes. In the polypharmacy model, significant predictors are other chronic conditions, medical complications, depression, and hypertension, all of which increase the likelihood of polypharmacy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high prevalence of both conditions reflects the substantial clinical burden in this population, emphasising the complexity of their care needs. Moreover, the study recommends that future research explore universal operational definitions of frailty in national practice to better align with global standards.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12912-025-03850-y","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:36:16Z","timestamp":1758882976000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Frailty and polypharmacy among geriatric home care patients: an epidemiological analysis and implications for optimised care"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-082X","authenticated-orcid":false,"given":"Khalid Abdullah","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"3850_CR1","unstructured":"World Health Organization. Ageing and health. 2022. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health"},{"issue":"4","key":"3850_CR2","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/ijerph17041439","volume":"17","author":"M Cristea","year":"2020","unstructured":"Cristea M, Noja GG, Stefea P, Sala AL. The impact of population aging and public health support on EU labor markets. Int J Environ Res Public Health. 2020;17(4):1439.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"3850_CR3","first-page":"585","volume":"36","author":"J Song","year":"2018","unstructured":"Song J, Ryu D. Aging effects on consumption risk-sharing channels in European countries. Zb Rad Ekon Fak Rij. 2018;36(2):585\u2013617.","journal-title":"Zb Rad Ekon Fak Rij"},{"issue":"3","key":"3850_CR4","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.3346\/jkms.2020.35.e16","volume":"35","author":"H Lee","year":"2020","unstructured":"Lee H, Lee E, Jang IY. Frailty and comprehensive geriatric assessment. J Korean Med Sci. 2020;35(3):e16.","journal-title":"J Korean Med Sci"},{"issue":"1","key":"3850_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-01747-w","volume":"20","author":"N Morkisch","year":"2020","unstructured":"Morkisch N, Upegui-Arango LD, Cardona MI, et al. Components of the transitional care model (TCM) to reduce readmission in geriatric patients: a systematic review. BMC Geriatr. 2020;20(1):1\u201318.","journal-title":"BMC Geriatr"},{"issue":"1","key":"3850_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.15537\/smj.2023.44.1.20220465","volume":"44","author":"MM Al-Amoud","year":"2023","unstructured":"Al-Amoud MM, Omar DI, Almashjary EN, Alomary SA. Morbidity profile among older people at primary health care centers in Saudi Arabia during the period 2012\u20132020. Saudi Med J. 2023;44(1):45.","journal-title":"Saudi Med J"},{"key":"3850_CR7","first-page":"1","volume":"1","author":"S Alsuwaidan","year":"2021","unstructured":"Alsuwaidan S, Algharbi A, Alyami S, Almukhlifi N, Alsalamah S. Prevalence of comorbidity among elderly. Glob J Aging Geriatr Res. 2021;1:1\u20138.","journal-title":"Glob J Aging Geriatr Res"},{"issue":"3","key":"3850_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jsps.2022.01.003","volume":"30","author":"MH Aljawadi","year":"2022","unstructured":"Aljawadi MH, Khoja AT, Alaboud NM, et al. Prevalence of polypharmacy and factors associated with it among Saudi older adults\u2013Results from the Saudi National survey for elderly health (SNSEH). Saudi Pharm J. 2022;30(3):230\u20136.","journal-title":"Saudi Pharm J"},{"key":"3850_CR9","doi-asserted-by":"publisher","first-page":"204209862093374","DOI":"10.1177\/2042098620933741","volume":"11","author":"M Khezrian","year":"2020","unstructured":"Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:2042098620933741.","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"3850_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/geriatrics4020036","volume":"4","author":"A Alsuwaidan","year":"2019","unstructured":"Alsuwaidan A, Almedlej N, Alsabti S, et al. A comprehensive overview of polypharmacy in elderly patients in Saudi Arabia. Geriatr (Basel). 2019;4(2):36.","journal-title":"Geriatr (Basel)"},{"issue":"1","key":"3850_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-020-1413-7","volume":"20","author":"BY Hailu","year":"2020","unstructured":"Hailu BY, Berhe DF, Gudina EK, Gidey K, Getachew M. Drug related problems in admitted geriatric patients: the impact of clinical pharmacist interventions. BMC Geriatr. 2020;20(1):1\u20138.","journal-title":"BMC Geriatr"},{"issue":"1","key":"3850_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1186\/s12877-022-03279-x","volume":"22","author":"M Delara","year":"2022","unstructured":"Delara M, Murray L, Jafari B, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022;22(1):601.","journal-title":"BMC Geriatr"},{"issue":"8","key":"3850_CR13","doi-asserted-by":"publisher","first-page":"e5880","DOI":"10.1002\/pds.5880","volume":"33","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu T, Su Q, et al. Prevalence of polypharmacy in elderly population worldwide: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2024;33(8):e5880.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3850_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-021-02142-9","volume":"21","author":"BA Alqahtani","year":"2021","unstructured":"Alqahtani BA, Alenazi AM, Alshehri MM, Osailan AM, Alsubaie SF, Alqahtani MA. Prevalence of frailty and associated factors among Saudi community-dwelling older adults: a cross-sectional study. BMC Geriatr. 2021;21:1\u20138.","journal-title":"BMC Geriatr"},{"issue":"6","key":"3850_CR15","first-page":"108","volume":"10","author":"BA Alqahtani","year":"2022","unstructured":"Alqahtani BA, Alshehri MM, Elnaggar RK, et al. Prevalence of frailty in the middle east: systematic review and meta-analysis. Healthc (Basel). 2022;10(6):108.","journal-title":"Healthc (Basel)"},{"issue":"8","key":"3850_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","volume":"60","author":"RM Collard","year":"2012","unstructured":"Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487\u201392.","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"3850_CR17","first-page":"895","volume":"10","author":"TL To","year":"2022","unstructured":"To TL, Doan TN, Ho WC, Liao WC. Prevalence of frailty among community-dwelling older adults in Asian countries: a systematic review and meta-analysis. Healthc (Basel). 2022;10(4):895.","journal-title":"Healthc (Basel)"},{"issue":"1","key":"3850_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ageing\/afaa219","volume":"50","author":"R O\u2019Caoimh","year":"2021","unstructured":"O\u2019Caoimh R, Sezgin D, O\u2019Donovan MR, et al. Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies. Age Ageing. 2021;50(1):96\u2013104.","journal-title":"Age Ageing"},{"key":"3850_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med. 2021;12:443\u201352.","journal-title":"Eur Geriatr Med"},{"key":"3850_CR20","unstructured":"World Health Organization. Frailty and intrinsic capacity VIII. 2017. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/272437\/WHO-FWC-ALC-17.2-eng.pdf"},{"issue":"1","key":"3850_CR21","doi-asserted-by":"publisher","first-page":"33267","DOI":"10.1525\/collabra.33267","volume":"8","author":"D Lakens","year":"2022","unstructured":"Lakens D. Sample size justification. Collabra Psychol. 2022;8(1):33267.","journal-title":"Collabra Psychol"},{"issue":"3","key":"3850_CR22","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","volume":"56","author":"LP Fried","year":"2001","unstructured":"Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol Biol Sci Med Sci. 2001;56(3):M146\u201357.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"2","key":"3850_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jsps.2017.11.008","volume":"26","author":"AT Khoja","year":"2018","unstructured":"Khoja AT, Aljawadi MH, Al-Shammari SA, et al. The health of Saudi older adults; results from the Saudi National survey for elderly health (SNSEH) 2006\u20132015. Saudi Pharm J. 2018;26(2):292\u2013300.","journal-title":"Saudi Pharm J"},{"key":"3850_CR24","unstructured":"Saudi Ministry of Health. Elderly comprehensive clinical file. 2018."},{"issue":"5","key":"3850_CR25","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/ageing\/afz088","volume":"48","author":"L Han","year":"2019","unstructured":"Han L, Clegg A, Doran T, Fraser L. The impact of frailty on healthcare resource use: a longitudinal analysis using the clinical practice research datalink in England. Age Ageing. 2019;48(5):665\u201371.","journal-title":"Age Ageing"},{"issue":"10206","key":"3850_CR26","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(19)31786-6","volume":"394","author":"EO Hoogendijk","year":"2019","unstructured":"Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365\u201375.","journal-title":"Lancet"},{"key":"3850_CR27","doi-asserted-by":"publisher","first-page":"1357171","DOI":"10.3389\/fphar.2024.1357171","volume":"15","author":"AA Alqurain","year":"2024","unstructured":"Alqurain AA, Albaharnah M, Al Zayer S, et al. The prevalence of polypharmacy and hyper-polypharmacy among middle-aged vs. older patients in Saudi arabia: a cross-sectional study. Front Pharmacol. 2024;15:1357171.","journal-title":"Front Pharmacol"},{"issue":"7","key":"3850_CR28","first-page":"327","volume":"55","author":"S Baldoni","year":"2019","unstructured":"Baldoni S, Amenta F, Ricci G. Telepharmacy services: present status and future perspectives: a review. Med (Kaunas). 2019;55(7):327.","journal-title":"Med (Kaunas)"},{"issue":"3","key":"3850_CR29","first-page":"422","volume":"11","author":"I D\u00edaz Planelles","year":"2023","unstructured":"D\u00edaz Planelles I, Navarro-Tapia E, Garc\u00eda-Algar \u00d3, Andreu-Fern\u00e1ndez V. Prevalence of potentially inappropriate prescriptions according to the new STOPP\/START criteria in nursing homes: a systematic review. Healthc (Basel). 2023;11(3):422.","journal-title":"Healthc (Basel)"},{"issue":"1","key":"3850_CR30","doi-asserted-by":"publisher","first-page":"21203","DOI":"10.1038\/s41598-023-48403-y","volume":"13","author":"F Nari","year":"2023","unstructured":"Nari F, Park EC, Nam CM, Jang SI. Impact of frailty on mortality and healthcare costs and utilization among older adults in South Korea. Sci Rep. 2023;13(1):21203.","journal-title":"Sci Rep"},{"issue":"1","key":"3850_CR31","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1186\/s12877-022-03439-z","volume":"22","author":"A \u00c1lvarez-Bustos","year":"2022","unstructured":"\u00c1lvarez-Bustos A, Rodr\u00edguez-S\u00e1nchez B, Carnicero-Carre\u00f1o JA, Sep\u00falveda-Loyola W, Garcia-Garcia FJ. Rodr\u00edguez-Ma\u00f1as L. Healthcare cost expenditures associated to frailty and sarcopenia. BMC Geriatr. 2022;22(1):747.","journal-title":"BMC Geriatr"},{"issue":"8","key":"3850_CR32","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2217\/cer-2018-0029","volume":"7","author":"KN Simpson","year":"2018","unstructured":"Simpson KN, Seamon BA, Hand BN, et al. Effect of frailty on resource use and cost for medicare patients. J Comp Eff Res. 2018;7(8):817\u201325.","journal-title":"J Comp Eff Res"},{"key":"3850_CR33","unstructured":"Polypharmacy and the Elderly. Reducing the risk of adverse events through monitoring and communication. 2021."}],"container-title":["BMC Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-025-03850-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12912-025-03850-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12912-025-03850-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:47:07Z","timestamp":1781614027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12912-025-03850-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3850"],"URL":"https:\/\/doi.org\/10.1186\/s12912-025-03850-y","relation":{},"ISSN":["1472-6955"],"issn-type":[{"value":"1472-6955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved a retrospective review of medical files. The research protocol was reviewed and approved by the Al Madinah Health Cluster, approval number (IRB33-22), which granted a waiver of informed consent. The waiver was based on the nature of the study: data were collected exclusively by members of the healthcare team, and no identifiable or private information was recorded or disclosed. All data were anonymised at the point of extraction, ensuring that patient confidentiality and privacy were fully protected in accordance with ethical and legal standards. The study was conducted in accordance with the guidelines and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1206"}}